Stevens Capital Management LP Has $1.02 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Stevens Capital Management LP lifted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 38,875 shares of the pharmacy operator’s stock after buying an additional 1,947 shares during the period. Stevens Capital Management LP’s holdings in Walgreens Boots Alliance were worth $1,015,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after acquiring an additional 10,962,030 shares in the last quarter. Invesco Ltd. boosted its holdings in Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after acquiring an additional 3,013,807 shares in the last quarter. Morgan Stanley boosted its holdings in Walgreens Boots Alliance by 15.8% in the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after acquiring an additional 1,720,228 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Walgreens Boots Alliance by 3.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,905,998 shares of the pharmacy operator’s stock worth $131,349,000 after acquiring an additional 212,161 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in Walgreens Boots Alliance by 12.4% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,077,336 shares of the pharmacy operator’s stock worth $80,349,000 after acquiring an additional 339,143 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded up $0.10 during trading hours on Friday, reaching $17.70. The stock had a trading volume of 6,586,367 shares, compared to its average volume of 13,817,973. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The stock has a 50 day simple moving average of $20.09 and a 200 day simple moving average of $21.81. Walgreens Boots Alliance, Inc. has a 12-month low of $17.49 and a 12-month high of $35.38. The stock has a market cap of $15.27 billion, a P/E ratio of -2.51, a price-to-earnings-growth ratio of 1.10 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.16 earnings per share. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Insider Activity

In related news, Director Valerie B. Jarrett purchased 4,456 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 29th. The stock was bought at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares in the company, valued at $99,992.64. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett acquired 4,456 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the purchase, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 13,456 shares of company stock worth $270,423. 17.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

WBA has been the topic of several recent research reports. Truist Financial reiterated a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Morgan Stanley dropped their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a report on Monday, April 1st. TD Cowen dropped their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Finally, Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.